Apex Biotechnology Corp
TWSE:1733
Wall Street
Price Targets
Price Targets Summary
Apex Biotechnology Corp
According to Wall Street analysts, the average 1-year price target for Apex Biotechnology Corp is 76.45 TWD .
Price Targets
Operating Income
Forecast
Operating Income Estimate
Apex Biotechnology Corp
For the last 8 years the compound annual growth rate for Apex Biotechnology Corp's operating income is -9%. The projected CAGR for the next 1 year is 57%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Apex Biotechnology Corp's stock price target?
Price Target
76.45
TWD
According to Wall Street analysts, the average 1-year price target for Apex Biotechnology Corp is 76.45 TWD .
What is Apex Biotechnology Corp's Revenue forecast?
Projected CAGR
47%
For the last 8 years the compound annual growth rate for Apex Biotechnology Corp's revenue is -1%. The projected CAGR for the next 1 year is 47%.
What is Apex Biotechnology Corp's Operating Income forecast?
Projected CAGR
57%
For the last 8 years the compound annual growth rate for Apex Biotechnology Corp's operating income is -9%. The projected CAGR for the next 1 year is 57%.
What is Apex Biotechnology Corp's Net Income forecast?
Projected CAGR
79%
For the last 8 years the compound annual growth rate for Apex Biotechnology Corp's net income is -10%. The projected CAGR for the next 1 year is 79%.